Marksans Pharma Ltd
NSE:MARKSANS

Watchlist Manager
Marksans Pharma Ltd Logo
Marksans Pharma Ltd
NSE:MARKSANS
Watchlist
Price: 308.3 INR 0.85% Market Closed
Market Cap: 139.7B INR
Have any thoughts about
Marksans Pharma Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

28.2
Current
8.7
Median
13.7
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
28.2
=
Enterprise Value
134.8B INR
/
EBITDA
4.8B INR
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
24
2-Years Forward
EV/EBITDA
19.4
3-Years Forward
EV/EBITDA
16

See Also

Discover More